聚乙二醇干扰素治疗慢性乙型肝炎致1型糖尿病1例报告

基金项目:

院长创新基金青年培育项目 (QNPY2015008)

利益冲突声明：所有作者均声明不存在利益冲突。

作者贡献声明：张婷婷负责资料分析，随访患者，撰写论文；赵珏参与查阅文献；杨彦、康姚洁负责拟定写作思路；王煊指导撰写文章并最后定稿。

详细信息

Type 1 diabetes mellitus due to pegylated interferon treatment of chronic hepatitis B: A case report

1.
Department of Endocrinology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China
2.
Department of Internal Medicine, Hospital of Army 95968 of PLA, Beijing 100195, China

Research funding:

The Innovation Fund Youth Cultivation Project (QNPY2015008)

表 1 患者口服葡萄糖耐量试验结果(75 g)

下载: 导出CSV

[1]	FABRIS P, BETTERLE C, FLOREANI A, et al. Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis[J]. Lancet, 1992, 340: 548. DOI: 10.1016/0140-6736(92)91744-s.
[2]	NEGRO F. Adverse effects of drugs in the treatment of viral hepatitis[J]. Best Pract Res Clin Gastroenterol, 2010, 24(2): 183-192. DOI: 10.1016/j.bpg.2009.10.012.
[3]	ZORNITZKI T, MALNICK S, LYSYY L, et al. Interferon therapy in hepatitis C leading to chronic type 1 diabetes[J]. World J Gastroenterol, 2015, 21(1): 233-239. DOI: 10.3748/wjg.v21.i1.233.
[4]	WAGURI M, HANAFUSA T, ITOH N, et al. Occurrence of IDDM during interferon therapy for chronic viral hepatitis[J]. Diabetes Res Clin Pract, 1994, 23(1): 33-26. DOI: 10.1016/0168-8227(94)90124-4.
[5]	SUKRAN K, GOZAYDIN A, AKKOCLU G, et al. Chronic hepatitis B with type I diabetes mellitus and autoimmune thyroiditis development during interferon alpha therapy[J]. Infect Dev Ctries, 2012, 6(4): 364-368. DOI: 10.3855/jidc.1632.
[6]	LV Y, SHI BY, GUO H. Abrupt onset of type 1 diabetes mellitus during recombinant interferon-alpha 2b therapy in a patient with chronic hepatitis B[J]. World J Gastroenterol, 2008, 14(29): 4713-4715. DOI: 10.3748/wjg.14.4713.